Patent · US Active

Alkyne compounds with MCH antagonistic activity and medicaments comprising these compounds

US7524862B2 · kind B2 · utility

1Cited by

4References

27Claims

0Family size

Assignee

Boehringer Ingelheim International GmbH · DE

Inventors

Dirk Stenkamp · Biberach, DE
Stephan Georg Mueller · Warthausen, DE
Philipp Lustenberger · Warthausen, DE
Thorsten Lehmann-Lintz · Ochsenhausen, DE
Gerald Juergen Roth · Biberach, DE
Klaus Rudolf · Warthausen, DE
Marcus Schindler · Schwäbisch Hall, DE
Leo Thomas · Biberach, DE
Ralf Lotz · Schemmerhofen, DE

Key dates

Filing date	Apr 13, 2005
Grant date	Apr 28, 2009
Priority date	—
Expiry date	Jul 19, 2026

Classification

Technology area (CPC C)Chemistry; Metallurgy
CPC primaryC07D405/14
WIPO fieldOrganic fine chemistry
WIPO sectorChemistry

Abstract

Alkyne compounds of formula Iwherein A, B, W, X, Y, Z, R1, and R2 have the meanings given herein, which have MCH-receptor antagonistic activity and are useful for preparing pharmaceutical compositions for the treatment of metabolic disorders and/or eating disorders, particularly obesity and diabetes.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.